Search results with tag "New drug listing amp pricing policies in china"

NEW DRUG LISTING & PRICING POLICIES IN CHINA

pricing for “premium-priced” drugs, the majority of which are manufactured by multi-national companies (MNCs). For the first time, the Ministry has begun to consider pharmacoeconomic and budget-impact evidence in its decision-making, signaling the need for global companies to approach the Chinese market differently in future.

  Drug, Global, Chain, Policies, Listing, Pricing, New drug listing amp pricing policies in china